ASO Author Reflections: Normothermic Intraperitoneal Chemotherapy Long-Term for Malignant Peritoneal Mesothelioma

被引:0
|
作者
Sugarbaker, Paul H. [1 ]
机构
[1] Washington Canc Inst, Program Peritoneal Surface Malignancy, Washington, DC 20010 USA
关键词
D O I
10.1245/s10434-021-10058-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
下载
收藏
页码:7118 / 7119
页数:2
相关论文
共 50 条
  • [31] ASO Visual Abstract: Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center
    Valenzuela, Cristian D.
    Solsky, Ian B.
    Erali, Richard A.
    Forsythe, Steven D.
    Mangieri, Christopher W.
    Mainali, Bigyan B.
    Russell, Gregory
    Perry, Kathleen C.
    Votanopoulos, Konstantinos I.
    Shen, Perry
    Levine, Edward A.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (05) : 2676 - 2677
  • [32] ASO Author Reflections: Repeated Intraperitoneal Paclitaxel with Systemic Chemotherapy as the First-Line Treatment for Peritoneal Malignancy
    Kitayama, Joji
    Saito, Shin
    Yamaguchi, Hironori
    Lefor, Alan Kawarai
    Ishigami, Hironori
    Sata, Naohiro
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (07) : 3871 - 3872
  • [33] Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival
    Sugarbaker, P. H.
    Chang, D.
    EJSO, 2017, 43 (07): : 1228 - 1235
  • [34] ASO Author Reflections: Is There Still a Role for Intraperitoneal Oxaliplatin for Colorectal Peritoneal Metastases?
    Taibi, Abdelkader
    Hubner, Martin
    Eveno, Clarisse
    Dumont, Frederic
    Glehen, Olivier
    Sgarbura, Olivia
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (08) : 5252 - 5253
  • [35] ASO Author Reflections: Repeated Intraperitoneal Paclitaxel with Systemic Chemotherapy as the First-Line Treatment for Peritoneal Malignancy
    Joji Kitayama
    Shin Saito
    Hironori Yamaguchi
    Alan Kawarai Lefor
    Hironori Ishigami
    Naohiro Sata
    Annals of Surgical Oncology, 2021, 28 : 3871 - 3872
  • [36] Long-term outcomes of cytoreduction and HIPEC for malignant peritoneal mesothelioma
    Bates, Gleneara Elizabeth
    Kluger, Michael D.
    Jin, Zhezhen
    Chabot, John A.
    Leinwand, Joshua
    Bressler, Toby
    Rae, Michelle
    Taub, Robert N.
    Borczuk, Alain C.
    Hesdorffer, Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] ASO Author Reflections: Is There Still a Role for Intraperitoneal Oxaliplatin for Colorectal Peritoneal Metastases?
    Abdelkader Taibi
    Martin Hübner
    Clarisse Eveno
    Frederic Dumont
    Olivier Glehen
    Olivia Sgarbura
    Annals of Surgical Oncology, 2022, 29 : 5252 - 5253
  • [38] MALIGNANT PERITONEAL MESOTHELIOMA - LONG-TERM SPONTANEOUS CLINICAL REMISSION
    SCHWARTZ, E
    MAAYAN, C
    MOUALLEM, M
    ENGELBERG, S
    FRIEDMAN, E
    MEDICAL AND PEDIATRIC ONCOLOGY, 1991, 19 (04): : 325 - 328
  • [39] ASO Author Reflections: Chyle Leak: No Long-Term Impact on Survival
    Milito, Pamela
    Phillips, Alexander W.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (07) : 3973 - 3974
  • [40] ASO Author Reflections: Chyle Leak: No Long-Term Impact on Survival
    Pamela Milito
    Alexander W. Phillips
    Annals of Surgical Oncology, 2021, 28 : 3973 - 3974